Your browser doesn't support javascript.
loading
Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells.
Dubash, Taronish D; Bardia, Aditya; Chirn, Brian; Reeves, Brittany A; LiCausi, Joseph A; Burr, Risa; Wittner, Ben S; Rai, Sumit; Patel, Hitisha; Bihani, Teeru; Arlt, Heike; Bidard, Francois-Clement; Kaklamani, Virginia G; Aftimos, Philippe; Cortés, Javier; Scartoni, Simona; Fiascarelli, Alessio; Binaschi, Monica; Habboubi, Nassir; Iafrate, A John; Toner, Mehmet; Haber, Daniel A; Maheswaran, Shyamala.
Afiliação
  • Dubash TD; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, 02114, USA.
  • Bardia A; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, 02114, USA.
  • Chirn B; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, 02114, USA.
  • Reeves BA; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, 02114, USA.
  • LiCausi JA; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, 02114, USA.
  • Burr R; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, 02114, USA.
  • Wittner BS; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, 02114, USA.
  • Rai S; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, 02114, USA.
  • Patel H; Radius Health, Inc, Waltham, MA, 02451, USA.
  • Bihani T; Radius Health, Inc, Waltham, MA, 02451, USA.
  • Arlt H; Radius Health, Inc, Waltham, MA, 02451, USA.
  • Bidard FC; Institut Curie, Paris, Saint Cloud, France.
  • Kaklamani VG; University of Texas Health Sciences Center, Houston, TX, 77030, USA.
  • Aftimos P; Institut Jules Bordet-Université Libre de Bruxelles, Brussels, Belgium.
  • Cortés J; International Breast Cancer Center (IBCC), Quiron Group, Barcelona, Spain.
  • Scartoni S; Menarini Group, Pomezia, Italy.
  • Fiascarelli A; Menarini Group, Pomezia, Italy.
  • Binaschi M; Menarini Group, Pomezia, Italy.
  • Habboubi N; Stemline Therapeutics/Menarini Group, New York, NY, 10022, USA.
  • Iafrate AJ; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, 02114, USA.
  • Toner M; Center for Engineering in Medicine, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
  • Haber DA; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, 02114, USA. dhaber@mgh.harvard.edu.
  • Maheswaran S; Howard Hughes Medical Institute, Bethesda, MD, 20810, USA. dhaber@mgh.harvard.edu.
Breast Cancer Res Treat ; 201(1): 43-56, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37318638
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Células Neoplásicas Circulantes Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Células Neoplásicas Circulantes Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article